These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28426141)

  • 1. Melanocortin 2, 3 and 4 Receptor Gene Expressions are Downregulated in CD8
    Andersen M; Nagaev I; Meyer MK; Nagaeva O; Wikberg J; Mincheva-Nilsson L; Andersen GN
    Scand J Immunol; 2017 Jul; 86(1):31-39. PubMed ID: 28426141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistin Gene Expression is Downregulated in CD4(+) T Helper Lymphocytes and CD14(+) Monocytes in Rheumatoid Arthritis Responding to TNF-α Inhibition.
    Nagaev I; Andersen M; Olesen MK; Nagaeva O; Wikberg J; Mincheva-Nilsson L; Andersen GN
    Scand J Immunol; 2016 Oct; 84(4):229-36. PubMed ID: 27434862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes.
    Andersen GN; Hägglund M; Nagaeva O; Frängsmyr L; Petrovska R; Mincheva-Nilsson L; Wikberg JE
    Scand J Immunol; 2005 Mar; 61(3):279-84. PubMed ID: 15787746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Aeberli D; Seitz M; Jüni P; Villiger PM
    Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of potent selective competitive-antagonists of the melanocortin type 2 receptor.
    Bouw E; Huisman M; Neggers SJ; Themmen AP; van der Lely AJ; Delhanty PJ
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):99-104. PubMed ID: 25017734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocortin receptors in rat liver cells: change of gene expression and intracellular localization during acute-phase response.
    Malik IA; Triebel J; Posselt J; Khan S; Ramadori P; Raddatz D; Ramadori G
    Histochem Cell Biol; 2012 Mar; 137(3):279-91. PubMed ID: 22183812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy.
    Dulic S; Vásárhelyi Z; Sava F; Berta L; Szalay B; Toldi G; Kovács L; Balog A
    Mediators Inflamm; 2017; 2017():6894374. PubMed ID: 29209104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1
    Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
    Front Immunol; 2018; 9():2241. PubMed ID: 30327652
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell signal transducer and activator of transcription (STAT) 4 and 6 are affected by adalimumab therapy in rheumatoid arthritis.
    Aerts NE; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
    Clin Exp Rheumatol; 2010; 28(2):208-14. PubMed ID: 20483042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Percentage of Signal Regulatory Protein α/β
    Magill L; Adriani M; Berthou V; Chen K; Gleizes A; Hacein-Bey-Abina S; Hincelin-Mery A; Mariette X; Pallardy M; Spindeldreher S; Szely N; Isenberg DA; Manson JJ; Jury EC; Mauri C
    Front Immunol; 2018; 9():2865. PubMed ID: 30568660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
    Bryl E; Vallejo AN; Matteson EL; Witkowski JM; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2005 Oct; 52(10):2996-3003. PubMed ID: 16200579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis.
    Kuuliala K; Kuuliala A; Koivuniemi R; Oksanen S; Hämäläinen M; Moilanen E; Kautiainen H; Leirisalo-Repo M; Repo H
    PLoS One; 2015; 10(9):e0137385. PubMed ID: 26353115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes.
    Sandhu A; Ahmad S; Kaur P; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2019 Jan; 38(1):37-44. PubMed ID: 29464523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.
    Blaschke S; Viereck V; Schwarz G; Klinger HM; Guerluek S; Müller GA
    Scand J Rheumatol; 2009; 38(4):235-9. PubMed ID: 19247848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory B cells in rheumatoid arthritis: Alterations in patients receiving anti-TNF therapy.
    Bankó Z; Pozsgay J; Gáti T; Rojkovich B; Ujfalussy I; Sármay G
    Clin Immunol; 2017 Nov; 184():63-69. PubMed ID: 28506920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.
    Grube M; Rezvani K; Wiestner A; Fujiwara H; Sconocchia G; Melenhorst JJ; Hensel N; Marti GE; Kwak LW; Wilson W; Barrett JA
    Clin Cancer Res; 2004 Feb; 10(3):1047-56. PubMed ID: 14871984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients.
    Mahmood Z; Schmalzing M; Dörner T; Tony HP; Muhammad K
    Front Immunol; 2020; 11():572475. PubMed ID: 33042152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis.
    Vigna-Pérez M; Abud-Mendoza C; Portillo-Salazar H; Alvarado-Sánchez B; Cuevas-Orta E; Moreno-Valdés R; Baranda L; Paredes-Saharopulos O; González-Amaro R
    Clin Exp Immunol; 2005 Aug; 141(2):372-80. PubMed ID: 15996202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.